ADHD Trial, Recruiting NCT06797726 Sponsor: University Hospital, Tours Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT06797726
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You are receiving treatment at an outpatient addiction department at the University Hospital of Brest, Nantes, or Tours, and you have been diagnosed with both ADHD and a behavioural addiction
  • You are enrolled in the French social security system
  • If you are currently taking methylphenidate (a medication for ADHD): your dose has not changed in the past three months
  • If you are not currently taking methylphenidate: there are no plans to start you on this medication in the next three months

Who may not be able to join:

  • People who have a psychotic disorder, as assessed by their doctor
  • Women who are pregnant or breastfeeding
  • People who are under legal guardianship or a similar form of protected supervision
  • People who are under court-ordered legal protection
  • People who are currently deprived of their liberty (for example, in prison)
  • People who are not considered suitable for Cognitive Behavioural Therapy (CBT), for example due to cognitive difficulties or hearing problems (confirm with trial site)
  • People who are physically unable to take part in CBT sessions, for example because they do not have access to a telephone or know they will be unavailable (confirm with trial site)
  • People who have difficulty understanding written questionnaires, including those who cannot read
  • People who are already taking part in another clinical study involving a different psychological therapy or medication that could affect the results of this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Servane BARRAULT, Dr, CHRU de Tours

Phone: (+33)2.47.47.91.91

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Tours
Registry
ClinicalTrials.gov
Start date
13 May 2025
Est. completion
1 August 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Retention rate; Adhesion; Adhesion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov